ENDRA Life Sciences Inc. (30)
Browse by Contract Category
Contracts
-
Description of Securities
(Filed With SEC on March 30, 2022)
-
At-The-Market Issuance Sales Agreement by and between ENDRA Life Sciences Inc. and Ascendiant Capital Markets, LLC, dated June 21, 2021
(Filed With SEC on June 21, 2021)
-
Second Amendment to Lease, dated March 15, 2021, by and between the Company and Green Court LLC
(Filed With SEC on March 25, 2021)
-
Underwriting Agreement, dated December 15, 2020
(Filed With SEC on December 18, 2020)
-
Non-Employee Director Compensation Policy
(Filed With SEC on August 14, 2020)
-
Description of Securities
(Filed With SEC on March 25, 2021)
-
At-The-Market Issuance Sales Agreement by and between ENDRA Life Sciences Inc. and Ascendiant Capital Markets, LLC, dated February 19, 2021
(Filed With SEC on February 19, 2021)
-
Amendment 4 to Collaborative Research Agreement, dated December 16, 2020, by and between the Company and General Electric Company
(Filed With SEC on December 21, 2020)
-
At-The-Market Issuance Sales Agreement by and between ENDRA Life Sciences Inc. and Ascendiant Capital Markets, LLC, dated September 25, 2020
(Filed With SEC on September 25, 2020)
-
U.S. Small Business Administration Paycheck Protection Program Note, issued by the Company to First Republic Bank
(Filed With SEC on May 14, 2020)
-
At The Market Offering Agreement by and between ENDRA Life Sciences Inc. and H.C. Wainwright & Co., LLC, dated March 27, 2020
(Filed With SEC on March 27, 2020)
-
Description of Securities
(Filed With SEC on March 26, 2020)
-
Amendment 3 to Collaborative Research Agreement, dated January 13, 2020, by and between the Company and General Electric Company
(Filed With SEC on January 15, 2020)
-
First Amendment to Employment Letter Agreement by and between the Company and Michael Thornton, dated December 27, 2019
(Filed With SEC on December 27, 2019)
-
First Amendment to Employment Letter Agreement by and between the Company and Francois Michelon, dated December 27, 2019
(Filed With SEC on December 27, 2019)
-
Form of Securities Purchase Agreement, dated December 19, 2019
(Filed With SEC on December 26, 2019)
-
Form of Warrant
(Filed With SEC on December 26, 2019)
-
Certificate of Designations of Series B Convertible Preferred Stock
(Filed With SEC on December 26, 2019)
-
Form of Registration Rights Agreement
(Filed With SEC on December 11, 2019)
-
Form of Securities Purchase Agreement dated December 5, 2019
(Filed With SEC on December 11, 2019)
-
Form of Warrant
(Filed With SEC on December 11, 2019)
-
Form of Certificate of Designations of Series A Convertible Preferred Stock
(Filed With SEC on December 11, 2019)
-
Employment Agreement, dated April 20, 2019, by and between the Company and Renaud Maloberti
(Filed With SEC on August 8, 2019)
-
Form of Security Agreement dated July 26, 2019
(Filed With SEC on July 29, 2019)
-
Form of Registration Rights Agreement dated July 26, 2019
(Filed With SEC on July 29, 2019)
-
Form of Securities Purchase Agreement dated July 26, 2019
(Filed With SEC on July 29, 2019)
-
Form of Warrant
(Filed With SEC on July 29, 2019)
-
Form of Convertible Promissory Note
(Filed With SEC on July 29, 2019)
-
Employment Agreement, dated May 13, 2019, by and between the Company and David Wells
(Filed With SEC on May 14, 2019)
-
Non-Employee Director Compensation Policy
(Filed With SEC on May 14, 2019)
